Page last updated: 2024-12-06
sintamil
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
sintamil: has pronounced sedative properties, but otherwise resembles imipramine; minor descriptor (77-84); on-line & Index Medicus search DIBENZOXAZEPINES (77-84); RN given refers to mono-HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 12195997 |
| MeSH ID | M0262778 |
Synonyms (22)
| Synonym |
|---|
| sintamil |
| 16398-39-3 |
| dibenz(b,f)(1,4)oxazepin-11(10h)-one, 10-(3-(dimethylamino)propyl)-2-nitro-, monohydrochloride |
| nitroxazepine hydrochloride |
| 10-(3-(dimethylamino)propyl)-2-nitrodibenz(b,f)(1,4)oxazepin-11(10h)-one monohydrochloride |
| einecs 240-449-1 |
| ciba 2330-go |
| 10-(3-(dimethylamino)propyl)-2-nitrobenz(b,f)(1,4)oxazepin-11(10h)-one hydrochloride |
| unii-y7lu3bj31l |
| y7lu3bj31l , |
| ciba-2330-go |
| nitroxazepine hydrochloride [who-dd] |
| 10-(3-(dimethylamino)propyl)-2-nitro-dibenz(b,f)(1,4)oxazepin-11(10h)-one monohydrochloride |
| ciba-2330go |
| dibenz(b,f)(1,4)oxazepin-11(10h)-one, 10-(3-(dimethylamino)propyl)-2-nitro-, hydrochloride (1:1) |
| 10-[3-(dimethylamino)propyl]-2-nitrodibenz[b,f][1,4]oxazepin-11(10h)-one monohydrochloride |
| dimethyl-[3-(8-nitro-6-oxobenzo[b][1,4]benzoxazepin-5-yl)propyl]azaniumchloride |
| DTXSID00936895 |
| 10-[3-(dimethylamino)propyl]-2-nitrodibenzo[b,f][1,4]oxazepin-11(10h)-one--hydrogen chloride (1/1) |
| 5-[3-(dimethylamino)propyl]-8-nitrobenzo[b][1,4]benzoxazepin-6-one;hydrochloride |
| Q27294354 |
| 10-(3-(dimethylamino)propyl)-2-nitrodibenzo[b,f][1,4]oxazepin-11(10h)-one hydrochloride |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (11.11%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (11.11%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (77.78%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||